KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. (KALV) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kalv · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$32.00
Consensus
$28.67
+6.2% upside
Low
$27.00
Median: $27 · Last Close: $26.99
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$28.67
6.2% upside
High Target
$32
18.6%
Low Target
$27
0.1%
Current Price
$26.99
as of today
Based on analyst price targets, the KALV stock price prediction for the next 12 months ranges from $27 to $32. The consensus KALV price forecast of $28.67 implies 6.2% upside from the current price of $26.99.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.02 | ↑ 0.14% |
1-day model range: $26.67–$27.38. Peak: $27.38 (+0.14%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $28 | +5.0% |
| 2028 | $29 | +7.9% |
| 2029 | $30 | +9.5% |
| 2030 | $30 | +10.5% |
| 2031 | — | +11.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KALV · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-01 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-04-30 | Needham | Downgrade ↓ | Buy→Hold |
| 2026-03-26 | Stifel | Maintains | Buy→Buy |
| 2026-03-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-25 | Needham | Maintains | Buy→Buy |
| 2026-01-09 | Needham | Maintains | Buy→Buy |
| 2026-01-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-06 | Needham | Maintains | Buy→Buy |
| 2025-12-04 | Needham | Maintains | Buy→Buy |
| 2025-11-11 | Citizens | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on KalVista Pharmaceuticals, Inc. (KALV) stock. Of the recent 60 rating actions, 0 were upgrades and 2 were downgrades. 13 analysts currently cover KALV.
Analyst Recommendation Trends
KALV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$199M
↓ 53.2% YoY
Revenue Next Year
$311M
↑ 56.2% YoY
EPS This Year
$-1.21
EPS Next Year
$0.64
↓ 152.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast KALV EPS of $-1.21 for the current fiscal year, based on estimates from 3 analysts. The KALV revenue forecast is $199M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KALV stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KALV price target is $28.67 (+6.2% upside), with an analyst consensus of Buy.
The KALV short-term stock prediction for tomorrow is $27.02 (+0.14%). The KALV stock price prediction for 2027 estimates an average of $28. The KALV stock prediction for 2030 projects a range of $26–$34.
KalVista Pharmaceuticals, Inc. trades on NASDAQ under the ticker KALV. The KALV stock outlook for 2027 is broadly positive, supported by a Buy consensus among 85% of covering analysts.
Frequently asked questions
KALV forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month KALV price target is $28.67, with a high forecast of $32.00 and a low of $27.00. The median price target is shown in the chart above when available. This implies +6.2% potential upside from the current price of $26.99.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.